Close Menu

NEW YORK – The GenomeWeb Index fell 1.8 percent in August, as biotech stocks stumbled amid wider market losses.

The index slightly underperformed the Dow Jones Industrial Average, which lost 1.7 percent, but outperformed the Nasdaq and the Nasdaq Biotechnology Index, which fell nearly 3 percent each. Individual stock performance in the GenomeWeb Index was mixed as 18 of the 30 stocks saw losses and 12 saw gains.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.